It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
CHD8, a major autism gene, functions in chromatin remodelling and has various roles involving several biological pathways. Therefore, unsurprisingly, previous studies have shown that intellectual developmental disorder with autism and macrocephaly (IDDAM), the syndrome caused by pathogenic variants in CHD8, consists of a broad range of phenotypic abnormalities. We collected and reviewed 106 individuals with IDDAM, including 36 individuals not previously published, thus enabling thorough genotype–phenotype analyses, involving the CHD8 mutation spectrum, characterization of the CHD8 DNA methylation episignature, and the systematic analysis of phenotypes collected in Human Phenotype Ontology (HPO). We identified 29 unique nonsense, 25 frameshift, 24 missense, and 12 splice site variants. Furthermore, two unique inframe deletions, one larger deletion (exons 26–28), and one translocation were observed. Methylation analysis was performed for 13 patients, 11 of which showed the previously established episignature for IDDAM (85%) associated with CHD8 haploinsufficiency, one analysis was inconclusive, and one showing a possible gain-of-function signature instead of the expected haploinsufficiency signature was observed. Consistent with previous studies, phenotypical abnormalities affected multiple organ systems. Many neurological abnormalities, like intellectual disability (68%) and hypotonia (29%) were observed, as well as a wide variety of behavioural abnormalities (88%). Most frequently observed behavioural problems included autism spectrum disorder (76%), short attention span (32%), abnormal social behaviour (31%), sleep disturbance (29%) and impaired social interactions (28%). Furthermore, abnormalities in the digestive (53%), musculoskeletal (79%) and genitourinary systems (18%) were noted. Although no significant difference in severity was observed between males and females, individuals with a missense variant were less severely affected. Our study provides an extensive review of all phenotypic abnormalities in patients with IDDAM and provides clinical recommendations, which will be of significant value to individuals with a pathogenic variant in CHD8, their families, and clinicians as it gives a more refined insight into the clinical and molecular spectrum of IDDAM, which is essential for accurate care and counselling.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Radboud University Medical Center, Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands (GRID:grid.10417.33) (ISNI:0000 0004 0444 9382)
2 University of Washington, Department of Psychiatry and Behavioral Sciences, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657)
3 University Medical Center Rotterdam, Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X)
4 University of Washington, Department of Genome Sciences, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657); University of Washington, Howard Hughes Medical Institute, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657)
5 University Medical Center Groningen, Department of Genetics, University of Groningen, Groningen, The Netherlands (GRID:grid.4494.d) (ISNI:0000 0000 9558 4598)
6 Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Human Genetics, Amsterdam, The Netherlands (GRID:grid.12380.38) (ISNI:0000 0004 1754 9227)
7 Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Human Genetics, Amsterdam, The Netherlands (GRID:grid.12380.38) (ISNI:0000 0004 1754 9227); VU University, Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam, the Netherlands (GRID:grid.12380.38) (ISNI:0000 0004 1754 9227)
8 London Health Sciences Centre, 1Verspeeten Clinical Genome Centre, London, Canada (GRID:grid.412745.1) (ISNI:0000 0000 9132 1600)
9 University of Amsterdam, Department of Clinical Genetics, Amsterdam UMC, Amsterdam, the Netherlands (GRID:grid.7177.6) (ISNI:0000000084992262)
10 Amphia Hospital, Department of Pediatrics, Breda, The Netherlands (GRID:grid.413711.1) (ISNI:0000 0004 4687 1426)
11 Greenwood Genetic Center, Greenwood, USA (GRID:grid.418307.9) (ISNI:0000 0000 8571 0933)
12 London Health Sciences Centre, 1Verspeeten Clinical Genome Centre, London, Canada (GRID:grid.412745.1) (ISNI:0000 0000 9132 1600); Western University, Department of Pathology and Laboratory Medicine, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884)
13 MUMC, Department of Clinical Genetics, Maastricht, The Netherlands (GRID:grid.412966.e) (ISNI:0000 0004 0480 1382); Maastricht University, GROW-School for Oncology and Reproduction, Maastricht, Netherlands (GRID:grid.5012.6) (ISNI:0000 0001 0481 6099)
14 MUMC, Department of Clinical Genetics, Maastricht, The Netherlands (GRID:grid.412966.e) (ISNI:0000 0004 0480 1382)
15 GeneDx, Gaithersburg, USA (GRID:grid.428467.b) (ISNI:0000 0004 0409 2707)




